Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
4(50%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_4
1
13%
Ph not_applicable
6
75%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution7 total trials
Phase 4Post-market surveillance
1(14.3%)
N/ANon-phased studies
6(85.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

50.0%

1 of 2 finished

Non-Completion Rate

50.0%

1 ended early

Currently Active

4

trials recruiting

Total Trials

8

all time

Status Distribution
Active(4)
Completed(1)
Terminated(1)
Other(2)

Detailed Status

Recruiting4
unknown2
Completed1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
4
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 41 (14.3%)
N/A6 (85.7%)

Trials by Status

completed113%
unknown225%
withdrawn113%
recruiting450%

Recent Activity

Clinical Trials (8)

Drug Details

Intervention Type
DEVICE
Total Trials
8